Vosoritide — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-01 in 1mo
ESTIMATED |
READOUT
Interventional Study of Vosoritide for the Treatment of Children With Hypochondr
Phase 3 · Hypochondroplasia |
BMRN BIOMARIN PHARMACEUTICAL INC | Vosoritide |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|